Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danyang Ji

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Nucleic Acids Research|October 23, 2023
Selective targeting of parallel G-quadruplex structure using L-RNA aptamerDanyang Ji, Jia-Hao Yuan, Shuo-Bin Chen, et al.
BMC Cancer|August 29, 2023
CDK4/6 inhibitors, PI3K/mTOR inhibitors, and HDAC inhibitors as second-line treatments for hormone receptor-positive, HER2-negative advanced breast cancer: a network meta-analysisDanyang Ji, Yang Luo, Jiayu Wang, et al.
Analytical Biochemistry|March 19, 2017
Label-free and rapid detection of ATP based on structure switching of aptamersDanyang Ji, Hongqi Wang, Jia Ge, et al.
Pharmaceutics|January 24, 2019
Interactions of Self-Assembled <i>Bletilla</i> S<i>triata</i> Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded NanoparticlesGuangyuan Zhang, Jin Qiao, Xin Liu, et al.
Pharmaceutics|January 25, 2025
Correction: Zhang et al. Interactions of Self-Assembled <i>Bletilla Striata</i> Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded Nanoparticles. <i>Pharmaceutics</i> 2019, <i>11</i>, 43Guangyuan Zhang, Jin Qiao, Xin Liu, et al.
The Oncologist|May 23, 2024
Adjuvant treatment strategy evolution and risk stratification for hormone receptor-positive, human epidermal growth factor receptor-2 negative early breast cancer in ChinaYing Fan, Danyang Ji, Mingxia Jiang, et al.
Journal of the American Chemical Society|June 3, 2025
Self-Generative Singlet Oxygen (<sup>1</sup>O<sub>2</sub>)-Initiated Chemical Modification of Nuclear DNAs Combats Tumor Drug ResistanceAnna Wang, Yuqi Zhang, Yurong Fan, et al.
Thoracic Cancer|April 3, 2025
Clinicopathological Factors That Predict Different Responses of Breast and Axillary Tumors to Neoadjuvant Chemotherapy and Prognosis Among Patients With Node-Positive Breast Cancer: Real World DataDanyang Ji, Bo Lan, Jiayu Wang, et al.
Medcomm|December 1, 2025
High-Plex Digital Spatial Profiling Identified Prolactin-Induced Protein mRNA Associated With Response and Survival of Everolimus and Letrozole Treatment for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerYuhang Han, Danyang Ji, Yujing Tan, et al.
Journal of the American Chemical Society|January 23, 2023
Tuning Material States and Functionalities of G-Quadruplex-Modulated RNA-Peptide CondensatesWei Guo, Danyang Ji, Andrew B Kinghorn, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Nucleic Acids Research|October 23, 2023
Selective targeting of parallel G-quadruplex structure using L-RNA aptamerDanyang Ji, Jia-Hao Yuan, Shuo-Bin Chen, et al.
BMC Cancer|August 29, 2023
CDK4/6 inhibitors, PI3K/mTOR inhibitors, and HDAC inhibitors as second-line treatments for hormone receptor-positive, HER2-negative advanced breast cancer: a network meta-analysisDanyang Ji, Yang Luo, Jiayu Wang, et al.
Analytical Biochemistry|March 19, 2017
Label-free and rapid detection of ATP based on structure switching of aptamersDanyang Ji, Hongqi Wang, Jia Ge, et al.
Pharmaceutics|January 24, 2019
Interactions of Self-Assembled <i>Bletilla</i> S<i>triata</i> Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded NanoparticlesGuangyuan Zhang, Jin Qiao, Xin Liu, et al.
Pharmaceutics|January 25, 2025
Correction: Zhang et al. Interactions of Self-Assembled <i>Bletilla Striata</i> Polysaccharide Nanoparticles with Bovine Serum Albumin and Biodistribution of Its Docetaxel-Loaded Nanoparticles. <i>Pharmaceutics</i> 2019, <i>11</i>, 43Guangyuan Zhang, Jin Qiao, Xin Liu, et al.
The Oncologist|May 23, 2024
Adjuvant treatment strategy evolution and risk stratification for hormone receptor-positive, human epidermal growth factor receptor-2 negative early breast cancer in ChinaYing Fan, Danyang Ji, Mingxia Jiang, et al.
Journal of the American Chemical Society|June 3, 2025
Self-Generative Singlet Oxygen (<sup>1</sup>O<sub>2</sub>)-Initiated Chemical Modification of Nuclear DNAs Combats Tumor Drug ResistanceAnna Wang, Yuqi Zhang, Yurong Fan, et al.
Thoracic Cancer|April 3, 2025
Clinicopathological Factors That Predict Different Responses of Breast and Axillary Tumors to Neoadjuvant Chemotherapy and Prognosis Among Patients With Node-Positive Breast Cancer: Real World DataDanyang Ji, Bo Lan, Jiayu Wang, et al.
Medcomm|December 1, 2025
High-Plex Digital Spatial Profiling Identified Prolactin-Induced Protein mRNA Associated With Response and Survival of Everolimus and Letrozole Treatment for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerYuhang Han, Danyang Ji, Yujing Tan, et al.
Journal of the American Chemical Society|January 23, 2023
Tuning Material States and Functionalities of G-Quadruplex-Modulated RNA-Peptide CondensatesWei Guo, Danyang Ji, Andrew B Kinghorn, et al.
Pageof 3